Aemetis (NASDAQ:AMTX) Director Timothy Alan Simon Sells 10,000 Shares

Aemetis, Inc (NASDAQ:AMTX) Director Timothy Alan Simon sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $2.05, for a total transaction of $20,500.00. Following the completion of the transaction, the director owned 42,632 shares in the company, valued at approximately $87,395.60. This trade represents a 19.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Aemetis Stock Performance

AMTX traded up $0.01 on Thursday, reaching $2.02. The company had a trading volume of 565,171 shares, compared to its average volume of 1,399,658. Aemetis, Inc has a 52-week low of $1.30 and a 52-week high of $3.80. The company has a market cap of $141.86 million, a price-to-earnings ratio of -1.69 and a beta of 1.36. The business has a 50 day simple moving average of $2.60 and a 200 day simple moving average of $2.01.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The firm had revenue of $54.62 million for the quarter, compared to analysts’ expectations of $66.70 million. As a group, equities research analysts predict that Aemetis, Inc will post -1.11 EPS for the current fiscal year.

Institutional Investors Weigh In On Aemetis

Several institutional investors have recently bought and sold shares of the stock. Goldman Sachs Group Inc. boosted its stake in shares of Aemetis by 71.9% during the first quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company’s stock valued at $380,000 after purchasing an additional 91,367 shares during the period. Creative Planning bought a new stake in Aemetis during the 2nd quarter valued at $30,000. Russell Investments Group Ltd. boosted its position in Aemetis by 412.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company’s stock valued at $200,000 after buying an additional 65,010 shares during the period. Jump Financial LLC purchased a new stake in Aemetis during the 2nd quarter valued at $64,000. Finally, Qube Research & Technologies Ltd bought a new stake in Aemetis in the 2nd quarter worth $246,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on AMTX shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a report on Monday, April 20th. Loop Capital set a $1.75 target price on Aemetis in a research report on Thursday, March 12th. Wall Street Zen lowered Aemetis from a “hold” rating to a “sell” rating in a research note on Saturday, June 6th. Finally, Ascendiant Capital Markets increased their price target on shares of Aemetis from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Aemetis currently has an average rating of “Hold” and a consensus target price of $8.92.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.